Darrin J. Bast
Toronto Centre for Antimicrobial Research and Evaluation (ToCARE)
Room 1483
Department of Microbiology
Mount Sinai Hospital
Canada
Name/email consistency: high
- Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance. Bast, D.J., Athamna, A., Duncan, C.L., de Azavedo, J.C., Low, D.E., Rahav, G., Farrell, D., Rubinstein, E. J. Antimicrob. Chemother. (2004)
- Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin. Bast, D.J., Yue, M., Chen, X., Bell, D., Dresser, L., Saskin, R., Mandell, L.A., Low, D.E., de Azavedo, J.C. Antimicrob. Agents Chemother. (2004)
- Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae. Bast, D.J., de Azavedo, J.C., Tam, T.Y., Kilburn, L., Duncan, C., Mandell, L.A., Davidson, R.J., Low, D.E. Antimicrob. Agents Chemother. (2001)